Search - tctmd.com

Displaying 701 - 720 of 2445

Sort: Relevancy | Date

Presentation TCT 2019

TAVR With Concomitant Complex Coronary Disease: Case Presentation and Management Strategies (Chronic CAD vs ACS Syndromes)

Presenter: David Hildick-Smith

September 26, 2019

Presentation TCT 2019

Infarct Artery PCI Only: CULPRIT Shock Provides the Answer!

Presenter: Holger Thiele

September 26, 2019

Presentation TCT 2019

Complete Revascularization in STEMI with MVD (Without Shock): Is the Story COMPLETE?

Presenter: Shamir Mehta

September 26, 2019

Presentation TCT 2019

Con: The Battle Is Won at the Front Line!

Presenter: William French

September 26, 2019

Presentation TCT 2019

Pro: The Only Way to Go!

Presenter: Tanveer Rab

September 26, 2019

Presentation TCT 2019

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

Presenter: Navin Kapur

September 26, 2019

Presentation TCT 2019

Advance Warning of Acute Coronary Syndrome Events (AngelMed): “Getting to the Church on Time”

Presenter: David Holmes Jr

September 26, 2019

Presentation TCT 2019

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

No Reflow: How to Prevent It and How to Fix It!

Presenter: Mitul Patel

September 26, 2019

Presentation TCT 2019

Case 1: A Patient With STEMI and Multivessel Disease

Presenter: Colin Berry

September 26, 2019

Presentation TCT 2019

A Woman’s Perspective!: Minoca, SCAD, Takotsubo, etc.

Presenter: Jacqueline Saw

September 26, 2019

Presentation TCT 2019

STEMI 2019: Who Are the High-Risk Patients?

Presenter: Andreas Baumbach

September 26, 2019

Presentation TCT 2019

When IVUS-OCT Guidance is a Need: Highly Calcified Lesions and ACS

Presenter: Francesco Prati

September 26, 2019

Presentation TCT 2019

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Role of PCSK9 Inhibitors Post-PCI and ACS

Presenter: Marc Bonaca

September 26, 2019

Presentation TCT 2019

SSO2 Therapy: Case Study

Presenter: Richard Schatz

September 26, 2019

Presentation TCT 2019

SSO2 Therapy: Clinical Evidence and Outcomes

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

SuperSaturated Oxygen Therapy: Background and Mechanism of Action

Presenter: James Spears

September 26, 2019

Presentation TCT 2019

Failed Therapeutic Approaches (Drugs and Devices) to Reduce Infarct Size

Presenter: E. Magnus Ohman

September 26, 2019

Presentation TCT 2019

Importance of Infarct Size and Microvascular Obstruction in STEMI

Presenter: Suzanne de Waha

September 26, 2019

Advertisement

TAVR With Concomitant Complex Coronary Disease: Case Presentation and Management Strategies (Chronic CAD vs ACS Syndromes)

Infarct Artery PCI Only: CULPRIT Shock Provides the Answer!

Complete Revascularization in STEMI with MVD (Without Shock): Is the Story COMPLETE?

Con: The Battle Is Won at the Front Line!

Pro: The Only Way to Go!

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

Advance Warning of Acute Coronary Syndrome Events (AngelMed): “Getting to the Church on Time”

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

No Reflow: How to Prevent It and How to Fix It!

Case 1: A Patient With STEMI and Multivessel Disease

A Woman’s Perspective!: Minoca, SCAD, Takotsubo, etc.

STEMI 2019: Who Are the High-Risk Patients?

When IVUS-OCT Guidance is a Need: Highly Calcified Lesions and ACS

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

Role of PCSK9 Inhibitors Post-PCI and ACS

SSO2 Therapy: Case Study

SSO2 Therapy: Clinical Evidence and Outcomes

SuperSaturated Oxygen Therapy: Background and Mechanism of Action

Failed Therapeutic Approaches (Drugs and Devices) to Reduce Infarct Size

Importance of Infarct Size and Microvascular Obstruction in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content